311 related articles for article (PubMed ID: 12171899)
1. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
Kiviharju TM; Lecane PS; Sellers RG; Peehl DM
Clin Cancer Res; 2002 Aug; 8(8):2666-74. PubMed ID: 12171899
[TBL] [Abstract][Full Text] [Related]
2. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
3. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
[TBL] [Abstract][Full Text] [Related]
4. Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells.
Lou YJ; Jin J
Leuk Lymphoma; 2004 Feb; 45(2):373-6. PubMed ID: 15101726
[TBL] [Abstract][Full Text] [Related]
5. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
[TBL] [Abstract][Full Text] [Related]
6. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
Wan CK; Wang C; Cheung HY; Yang M; Fong WF
Cancer Lett; 2006 Sep; 241(1):31-41. PubMed ID: 16316721
[TBL] [Abstract][Full Text] [Related]
7. Triptolide and its expanding multiple pharmacological functions.
Liu Q
Int Immunopharmacol; 2011 Mar; 11(3):377-83. PubMed ID: 21255694
[TBL] [Abstract][Full Text] [Related]
8. Triptolide induces apoptosis in endometrial cancer via a p53‑independent mitochondrial pathway.
Wang XF; Zhao YB; Wu Q; Sun ZH; Li HJ
Mol Med Rep; 2014 Jan; 9(1):39-44. PubMed ID: 24213358
[TBL] [Abstract][Full Text] [Related]
9. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
10. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
12. Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.
Johnson SM; Wang X; Evers BM
J Surg Res; 2011 Jun; 168(2):197-205. PubMed ID: 19922946
[TBL] [Abstract][Full Text] [Related]
13. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway.
Chang WT; Kang JJ; Lee KY; Wei K; Anderson E; Gotmare S; Ross JA; Rosen GD
J Biol Chem; 2001 Jan; 276(3):2221-7. PubMed ID: 11053449
[TBL] [Abstract][Full Text] [Related]
14. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
[TBL] [Abstract][Full Text] [Related]
15. MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status.
Li W; Liu Y; Li XX; Yu Y; Wu JJ; Wang Q; Huo H; Wang LM; Yang L
Planta Med; 2011 Jan; 77(1):27-31. PubMed ID: 20607649
[TBL] [Abstract][Full Text] [Related]
16. Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.
Wu PP; Liu KC; Huang WW; Ma CY; Lin H; Yang JS; Chung JG
Oncol Rep; 2011 Feb; 25(2):551-7. PubMed ID: 21152873
[TBL] [Abstract][Full Text] [Related]
17. Triptolide sensitizes liver cancer cell lines to chemotherapy in vitro and in vivo.
Li Y; Hu S
Panminerva Med; 2014 Sep; 56(3):211-20. PubMed ID: 24352031
[TBL] [Abstract][Full Text] [Related]
18. Does triptolide induce lysosomal-mediated apoptosis in human breast cancer cells?
Messina ME; Halaby R
Med Hypotheses; 2011 Jul; 77(1):91-3. PubMed ID: 21486687
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression.
Guo Q; Nan XX; Yang JR; Yi L; Liang BL; Wei YB; Zhu N; Hu SB; Zhang H; Luo Y; Xu YF
Neoplasma; 2013; 60(6):598-604. PubMed ID: 23906293
[TBL] [Abstract][Full Text] [Related]
20. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
Nakazato T; Sagawa M; Kizaki M
Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
